Not_yet_recruitingEARLY_PHASE1NCT07551063

Evaluating the Feasibility of 5G-Based Telerobotic Hepatectomy for Hepatic Echinococcosis in High-Altitude Regions: A Prospective, Single-Arm Study

Sponsor: West China Hospital

Trial Details

Condition	Hepatic Echinococcosis
Intervention	5G-based Telerobotic Hepatectomy
Phase	EARLY_PHASE1
Status	Not_yet_recruiting
Participants	10
Est. Completion	1 Oct 2026
Last Updated	24 Apr 2026

Primary Outcome

Technical Success Rate of 5G-based Telerobotic Hepatectomy

Eligibility Criteria

Inclusion Criteria

Inclusion Criteria: * Aged 18-80 years. * Diagnosed with hepatic echinococcosis with indications for hepatectomy. * Suitable for laparoscopic/robotic surgery (Child-Pugh Class A or B). * Voluntary signed informed consent. Exclusion Criteria: * Complex cases requiring vascular reconstruction (e.g., advanced alveolar echinococcosis). * Severe cardiopulmonary dysfunction or coagulopathy. * Pregnancy or lactation. * Recent participation in other clinical trials.

Trial Sites

Countries

China

View Registry Entry

Related Analysis

First-in-Human 5G Telerobotic Hepatectomy Trial Opens for Hepatic Echinococcosis — Remote Surgery at 3650m Altitude

First-in-human trial evaluates 5G-enabled remote robotic hepatectomy for hepatic echinococcosis, with expert surgeons in Chengdu operating on patients 3650m above sea level in Tibet. This groundbreaking study could revolutionise surgical access in remote regions globally.

Read full article →

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service